Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate for metabolic risk in obese Hispanics
NCT02130804Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Jul 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing Salsalate with Placebo (2 arms). Primary endpoints: Change in adipose tissue inflammation (macrophage infiltration) at 4 weeks, Change in liver fat at 4 weeks and 6 more. Started Jul 2011; status: completed.
02
Drugs
Amigesic
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02130804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130804.